Astellas Pharma Inc (OTCPK:ALPMF)
$ 11.1275 0 (0%) Market Cap: 20.04 Bil Enterprise Value: 23.95 Bil PE Ratio: 56.39 PB Ratio: 2.01 GF Score: 87/100

Astellas Pharma Inc Corporate- wide Digital Transformation Driven by Analytics Briefing Transcript

Mar 27, 2023 / NTS GMT
Release Date Price: $14.13
Hiromitsu Ikeda
Astellas Pharma Inc. - Corporate Head of Advocacy & Relations

Thank you very much for your participation for this meeting of Astellas' Corporate-wide Digital Transformation Driven by Analytics despite of your very busy schedule. I'm Hiro Ikeda, the VP of the Corporate advocacy in Relations division. First, let me explain you how to ask the questions for this session at the end of this meeting. (Operator Instructions) And this material is available on the website and in line with the presentation material, we would like to go through this seminar. So the participants for here today is the CTO and also Vice President, Naoki Okamura; and also Senior Director of Advanced Informatics and Analytics, Masanori Ito. So there are 2 speakers here today. This material or representation by representatives for the company and answers and statements by representatives for the company in the Q&A session includes the forward-looking statements based on assumptions and beliefs in light of the information currently available to management and subject to significant risks and uncertainties.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot